3 results
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
12 Feb 24
Regulation FD Disclosure
5:23pm
98,976,392 Clean cap table – no ratchets/resets/ACEs; No debt Pro forma cash (30sep2023) ~$34M* Feb2024 completed PIPE up to $45M ($15M upfront) with ADAR1
FWP
KPRX
Kiora Pharmaceuticals Inc
15 May 23
Free writing prospectus
5:18pm
3,931,299 As of March 31, 2023 Cash & Equivalents $3.4M ELOC Available* ~$9.6M R&D Credit Tax Receivables $1.7M Clean cap table – no ratchets/resets/ACEs
FWP
KPRX
Kiora Pharmaceuticals Inc
14 Jul 22
Free writing prospectus
5:14pm
-Ѵ;m|v ~$7.9M Clean cap table – no ratchets/resets No debt
30 Leadership Team Brian M Strem, PhD President & CEO Susan Drexler, CPA Financial
- Prev
- 1
- Next